O'Brien Greene & Co’s Crocs CROX Stock Holding History

O'Brien Greene & Co’s Portfolio CROX Stock Details CROX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,562	Closed	-$732K	–	138
2025 Q4	$732K	Buy	8,562 +500	+6%	+$41.8K	0.22%	66
2025 Q3	$674K	Buy	+8,062	New	+$736K	0.21%	70

Other funds holding CROX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WPA

WIT Partners Advisory Singapore $342M AUM 8.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

O'Brien Greene & Co's CROX Position: Q1 2026 in Review

O'Brien Greene & Co sold out of Crocs (CROX) in Q1 2026, closing a stake of 8,562 shares — an estimated $732K sold.

O'Brien Greene & Co first reported a position in CROX in Q3 2025 and held it in 2 quarters. The position peaked at $732K in Q4 2025. 456 funds tracked by Wall St. Rank hold CROX as of Q1 2026.

O'Brien Greene & Co reported no remaining Crocs position as of Q1 2026 after selling out during the quarter.
O'Brien Greene & Co sold 8,562 Crocs shares in Q1 2026, an estimated $732K.
O'Brien Greene & Co first reported a position in Crocs in Q3 2025 and held it in 2 quarters.
O'Brien Greene & Co's Crocs position peaked at $732K in Q4 2025.
456 funds tracked by Wall St. Rank held Crocs as of Q1 2026.

Based on O'Brien Greene & Co's 13F filing for Q1 2026, filed 6 May 2026.